NUFYMCO
NDC 70710-2172, ranibizumab-leyk, injection, solution, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-2172
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761473
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANIBIZUMAB.3 mg/.05mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-2172-1 | 70710217201 | 1 VIAL, GLASS in 1 CARTON (70710-2172-1) / .05 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/05ed75bc-ae21-480b-9be4-cbc51689dd8a
Use it
Look up 70710-2172 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-2172. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.